Burrill on Biotech - BioPharm International

ADVERTISEMENT

Burrill on Biotech

Biotech IPOs on a Hot Streak

April 1, 2014

Life-sciences companies continue upward momentum in 2014.

Life-Sciences IPOs Take a Breather

January 1, 2014

Frenzy cools as investors seeking a quick return turn elsewhere.

Robust IPO Market for Life Sciences Sparks Change Among Investors

October 1, 2013

Early-stage companies are now embraced by buyers of new issues.

IPO Market Heats Up for Life-Sciences Companies

July 1, 2013

Biotech companies raise most money in 13 years.

Financing Innovation

April 1, 2013

Early-stage companies are finding alternatives to venture capital.

Accelerating Change Marks 2012 for Life Sciences

January 1, 2013

A handful of therapeutics have performed extremely well in 2012, but as a whole, life-sciences are still down from 2010.

Recent Therapeutics IPOs Outshine Market, but Performance Mixed for Broader Life-Sciences Issues

October 1, 2012

A handful of therapeutics have performed extremely well in 2012, but as a whole, life-sciences are still down from 2010.

Pharmaceutical Dealmaking Broadens its Partnering Base

July 1, 2012

Collaborative R&D models coincide with new ways to fund translational research.

A Strong Start to 2012

April 1, 2012

Better news about the global economy buoys life-sciences funding.

ADVERTISEMENT

ADVERTISEMENT

Click here